The results showed that Pt-HFn, when combined with radiotherapy, outperformed sodium glycididazole-a widely used clinical radiosensitizer. The treatment demonstrated superior therapeutic efficacy in ...

He, L., Wang, X., Liu, K., et al. (2019) Integrative PDGF/PDGFR and Focal Adhesion Pathways Are Downregulated in ERCC1-Defective Non-Small Cell Lung Cancer Undergoing Sodium Glycididazole-Sensitized ...

Actin, a highly conserved protein, plays a dominant role in Non-small cell lung cancer (NSCLC). Late diagnosis and the aggressive nature of NSCLC pose a significant threat. Studying the clinic ...

Association between X-ray repair cross-complementing group 1 gene polymorphisms and glioma risk: a systematic review and meta-analysis based on 22 case-control studies ...

The Radiosensitization of sodium glycididazole on nasopharyngeal carcinoma cells via enhancing DNA damage and promoting apoptosis. J Cancer 2019; 10 (2):305–12. 37 Li MY, Liu JQ, Chen DP, Qi B, Liang ...

To improve the sensitization of radiotherapy, a few products have been developed and applied in clinical settings, namely, radiosensitizers such as irisquinone capsules and sodium glycididazole for ...

In the systematic review there was only one study specific to thyroid cancer (25), in which the effect of glycididazole sodium was explored. Glycididazole sodium is used as a radiosensitizing agent ...

A larger study was not able to confirm the latter. Improved PFS was reported with use of metronidazole, sodium glycididazole, and chloroquine. There was a wide range of toxicities which prompted ...

SHANGHAI, June 7, 2018 /PRNewswire/ -- China's Luye Pharma Group Ltd. has partnered up with U.S. biotech firm Elpis Biopharmaceuticals Corp. to work on dual target based therapies for cancer ...

SHANGHAI, June 7, 2018 /PRNewswire/ -- China’s Luye Pharma Group Ltd. has partnered up with U.S. biotech firm Elpis BioMed to work on dual target based therapies for cancer patients who fail to ...